Carter Healthcare: The Therapy Quota Behind the Florida Allegations

Carter Healthcare, with its president and chief operations officer, agreed to pay $7.175 million to resolve therapy fraud allegations involving unnecessary treatment and diagnosis upcoding in Florida. Two former Carter therapists brought the False Claims Act qui tam case. Their complaint describes a business allegedly setting visit totals before clinical consultations, pressing for recertification after therapists recommended discharge, and telling staff to leave information out of therapy notes. For a therapist who has watched a patient’s care plan bend toward a billing target, the details are familiar territory.

The Justice Department’s October 18, 2022 announcement described Carter as an Oklahoma-based, for-profit home health provider. The government alleged that its Florida operation knowingly billed Medicare for therapy without regard to medical necessity and upcoded patients’ diagnoses from 2014 through 2016.

Therapy Before the Clinical Decision

The whistleblowers’ complaint alleged that Carter mandated eighteen visits per patient during a sixty-day certification period, often scheduling the visits before consulting nurses or therapists. The complaint said the company chose the number to avoid government detection and an audit. It also alleged that a nurse would add speech therapy when physical or occupational therapy could not be justified, to meet the quota and maximize Medicare billing.

That is the alleged inversion at the center of this case: decide how much therapy the business wants, then find a clinical reason to supply it. The patient’s needs come second. Taxpayers get the bill.

The complaint also described a patient who refused treatment on seven occasions, yet whose attempted visits Carter allegedly billed to Medicare. A therapist at the door, a patient declining treatment, and a completed bill tell different stories about the same appointment. That difference matters to someone who knows what happened inside the home.

An Assessment That Made the Improvement Look Bigger

The whistleblowers alleged that Carter instructed nurses to falsify initial OASIS assessments by recording patients as having very low capabilities. According to the complaint, the low starting scores made patients appear to improve more by discharge, giving an exaggerated impression that Carter’s services were successful and necessary.

The allegation concerns both ends of the clinical story: how the patient looked on admission and how much better the patient appeared later. A therapist’s observations can challenge either end. The government’s settlement announcement separately identified diagnosis upcoding as a way Carter allegedly overbilled for therapy.

The complaint quoted an internal email that put the pressure on the therapy note itself:

We see the problem in that instruction. A clinical note is being asked to carry only the facts that support continued care. What the therapist saw, and what the bill needs the therapist to have seen, can part company right there.

When Discharge Became Another Recertification

The complaint alleged that Carter had an internal goal of treating every patient for at least six months and preferred keeping patients for at least a year, regardless of need. It described instructions to find reasons to recertify patients and additional paid time off for offices that met year-end certification goals.

One employee message quoted in the complaint celebrated the result:

Saved for whom? The alleged business success was keeping a patient on service after discharge had been in view.

The whistleblowers also alleged that when a therapist protested keeping a patient, Carter moved the patient to another therapist’s caseload. The complaint said earlier treatment records did not always follow the patient and alleged that this concealed prior discharge recommendations from the replacement therapist. That makes the handoff itself part of the story: who recommended discharge, who ordered continued treatment, and what the next therapist was allowed to see.

Why the Old Therapy Payment System Matters

Carter’s Florida allegations arose under the older home health payment system, when therapy volume could move a sixty-day episode into a higher payment category. The Centers for Medicare and Medicaid Services’ 2008 payment refinements introduced therapy thresholds at six, fourteen, and twenty visits. Those payment incentives help explain why a visit count could become a business target.

The Patient-Driven Groupings Model began on January 1, 2020. It changed the payment unit to thirty-day periods and removed therapy-volume thresholds from the payment grouping. Carter’s Florida conduct period preceded that change.

The newer model uses diagnoses and OASIS functional assessments to help set payment, and medical necessity still matters. For a healthcare insider, the question remains whether the clinical information supports the payment.

The same tension between clinical findings and payment inputs appears in the Amedisys whistleblower complaint. There, a nurse alleged that billing coordinators pressured nurses to alter OASIS information and list diabetes as the primary diagnosis even when it was unrelated to the reason for home care. The useful parallel is the person between the bedside assessment and the submitted information who can push the clinical account toward a better-paying diagnosis.

What Evidence Is Needed to Prove Fraud?

In a therapy case, the useful evidence connects what the patient needed, what clinicians recorded, what management directed, and what Medicare paid. The Carter complaint supplies concrete examples: visits scheduled before consultation, an instruction about what to omit from a SOAP note, and discharge recommendations allegedly lost when patients changed therapists.

We work with you to connect those pieces. A changed diagnosis, an omitted observation, and a decision to continue treatment each point to a different person and a different decision. The strongest account explains how those decisions reached a particular claim.

What Carter and Its Managers Agreed to Pay

The Florida resolution assigned $6.925 million to Carter Healthcare, $175,000 to its chief operations officer, and $75,000 to its president. Both managers also agreed to five-year exclusions from participation in federal health care programs as part of the civil resolution. The government’s investigation was handled by the U.S. Attorney’s Office for the Southern District of Florida, the Justice Department Civil Division’s Commercial Litigation Branch, and the Department of Health and Human Services Office of Inspector General.

The Separate Oklahoma and Texas Referral Settlement

The Oklahoma and Texas settlement addressed allegations that Carter improperly paid home health medical directors to induce Medicare and TRICARE referrals from 2013 through 2020. The Oklahoma announcement stated a separate payment obligation of $22,948,004.

That case follows the money paid to referral sources. The Florida therapy case follows clinical need, diagnosis coding, and the services billed.

What the Florida Corporate Integrity Agreement Required

The CHC-FLA corporate integrity agreement, effective September 26, 2022, imposed a five-year compliance program covering the entities providing home health services in Florida. Its independent claims review connected medical necessity, documentation, coding, and payment.

A paid claim without supporting documentation counted as an error, and its full reimbursement counted as an overpayment. The reviewer could not replace it with another claim. The first random sample had to be used.

If the reviewer accepted additional documents after the initial review, the report had to identify those materials, when they arrived, why they were accepted, and how much weight they received. That requirement preserves a distinction an insider will recognize: what supported the bill when someone first examined it, and what appeared later to defend it.

The independent review requirement could be suspended for a reporting year if CHC-FLA certified that every Medicare fee-for-service home health claim submitted and reimbursed during that year had undergone prepayment review under the Centers for Medicare and Medicaid Services’ Review Choice Demonstration. The wider compliance program remained required.

How Much Can a Medicare Fraud Whistleblower Receive?

A whistleblower case under the False Claims Act can pay 15% to 30% of what the government recovers. In the Carter Florida settlement, the Justice Department announced that the two former therapists would together receive $1.3 million as their share.

The clinical perspective mattered to the account they brought: what justified therapy, what supported discharge, and what the company’s instructions asked staff to put in the record. Those are business decisions a therapist can see from inside a patient’s care.

When Your Clinical Judgment Was Pushed Aside

If you saw a discharge recommendation become another round of therapy, or a clinical note change to support the bill, speak to one of our Whistleblower Experts. We build the case with you and bring in home health fraud whistleblower lawyers who understand therapy documentation, payment incentives, and management pressure. We stay beside you from the first discussion of the patient’s care through the pursuit of recovery.